Patents by Inventor Patrick Plesiat

Patrick Plesiat has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GOLD (I)-PHOSPHINE 1,2,3-TRIAZOLE DERIVATIVES WITH ANTIBIOTIC PROPERTIES
    Publication number: 20210284668
    Abstract: The present invention relates to gold (I)-phosphine 1,2,3-triazole compounds, and their use in a human or animal medicine. The present invention also relates to using such compounds for the prevention and/or treatment of an infection, i.e. inhibitors of growth of Gram-positive and/or Gram-negative bacteria. On another aspect the invention relates to the synthesis of the gold (I)-phosphine compounds of the invention and to their synthesis intermediates. The present invention finds applications in the medical, veterinary and/or chemical fields.
    Type: Application
    Filed: June 17, 2019
    Publication date: September 16, 2021
    Inventors: Gaëtan Mislin, Isabelle Schalk, Patrick Plésiat, Aurélie Paulen
  • DNA segments and transformed microorganisms comprising the delta.sup.1 -dehydrogenase gene pseudomonas testosteroni, and uses thereof
    Patent number: 5674718
    Abstract: Nucleic acids segment comprising a nucleotide coding sequence for Pseudomonas testosteroni .DELTA.1-dehydrogenase or an homologous or complementary nucleotide sequences thereof.
    Type: Grant
    Filed: February 17, 1994
    Date of Patent: October 7, 1997
    Assignee: Roussel Uclaf
    Inventors: Yvon Michel-Briand, Patrick Plesiat